Clotrimazole Vaginal Tablets/Cream bulk supplier for pharma manufacturers

Clotrimazole Vaginal Tablets/Cream Suppliers & Bulk Manufacturers

Available Forms: Vaginal Tablets/Cream

Available Strengths: 10 mg, 100 mg, 200 mg (vaginal tablets), 1% (cream)

Reference Brands: Mycelex(US); Fungusil(EU)

Clotrimazole vaginal tablets and cream inhibit fungal cytochrome P450 14α-demethylase, disrupting ergosterol synthesis and damaging fungal cell membranes. They effectively treat vaginal candidiasis, offering benefits like targeted therapy, rapid symptom relief, broad antifungal activity, minimal systemic absorption, and high safety, making them a reliable choice for vaginal fungal infections.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Clotrimazole vaginal tablets and creams are approved in the EU and US for treating vaginal candidiasis. In the EU, brands like Canesten are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA-approved clotrimazole vaginal products, including tablets and creams, are backed by comprehensive clinical data and pharmacovigilance requirements. Both regions require detailed dossiers for approval, ensuring product safety and efficacy. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate efficient market entry for clotrimazole vaginal formulations, helping you meet European and American standards for safe, effective antifungal therapy.

Clotrimazole Vaginal Tablets/Cream — third party manufacturing & bulk supply

Clotrimazole Vaginal Tablets/Cream is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Clotrimazole Vaginal Tablets/Cream is supplied as Vaginal Tablets/Cream — supplied in more than one dosage form, each with its own manufacturing economics, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Clotrimazole Vaginal Tablets/Cream listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Clotrimazole Vaginal Tablets/Cream →

Back to Listing

Frequently Asked Questions

Clotrimazole is used to treat vaginal yeast infections (vulvovaginal candidiasis) caused by Candida species. It helps relieve symptoms such as itching, burning, and abnormal discharge by disrupting fungal cell membrane formation, ultimately stopping fungal growth and clearing the infection.

Clotrimazole contains the active imidazole antifungal compound clotrimazole. The formulation includes suitable pharmaceutical excipients that ensure effective delivery and absorption in the vaginal area.

Common trade names for clotrimazole include Canesten and Gyne-Lotrimin, used widely in the USA, EU, UK, and other international markets.

Canesten-branded clotrimazole is manufactured by Bayer. Gyne-Lotrimin is produced by various licensed manufacturers depending on region. Numerous GMP-certified companies also produce generic clotrimazole for global supply.

The generic name is clotrimazole.

Common brand names include Canesten and Gyne-Lotrimin.

Clotrimazole is manufactured in multiple GMP-certified facilities worldwide, including Bayer’s regulated production units in Europe and other approved global manufacturers supplying generic clotrimazole to international markets.